Page 27 - Segundo Número 2017
P. 27
Ochoa-Nava R y cols. Amiloidosis de cadenas ligeras
5. Bilginer Y, Tekin A, Ozen S. Renal amyloidosis in children. Pediatr 10. Nicasio HR. Amiloidosis. Revista de la Facultad de Medicina. 2005;
Nephrol 2011; 26(8): 1215-1227. 6(1): 3-7.
6. Gillmore JD, Helen LJ. Amyloidosis. In: Harber M. Practical 11. Rajkumar V. Prognosis and treatment of immunoflobulin light chain
nephrology. London: Springer. 2014, pp. 311-322. amyloidosis and light and heavy chain deposition diseases. 2016;
7. Meiorin SM, Espada G. Enfermedades autoinflamatorias en UpToDate. Recuperado el 13 de Oct de 2016, de Wolters Kluwer:
pediatría. Arch Argent Pediatr. 2013; 111(3): 237-243. https://www.uptodate.com/contents/prognosis-and-treatment-of-
8. Dörler J, Pölzl G. Cardiac amyloidosis. Magazine of European immunoglobulin-light-chain-al-amyloidosis-and-light-and-heavy-
Medical Oncology. 2012; 5: 4-10. chain-deposition-diseases/
9. Manoli I, Kwan JY, Wang Q, Rushing EJ, Tsokos M, Arai AE et al. 12. Chari A, Barley K, Jagannath S, Osman K. Safety and efficacy of
Chronic myopathy due to immunoglobulin light chain amyloidosis. triplet regimens in newly diagnosed light chain amyloidosis. Clin
Mol Genet Metab. 2013; 108: 249-254. Lymphoma Myeloma Leuk. 2013; 13(1): 55-61.
www.medigraphic.org.mx
29
Rev Mex Pediatr 2017; 84(1); 25-29
